CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 41 enrolled
Drug / intervention
Baked non-fat cow's milk powder +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03462030
NCT03462030Phase 2Completed
CompareCT.gov

Phase II Study of Baked Milk Oral Immunotherapy for the Treatment of Cow's Milk Allergy

Johns Hopkins University·interventional·Posted Mar 12, 2018·Updated Feb 4, 2025

In Brief

A Phase 2 clinical trial evaluating Baked non-fat cow's milk powder and Placebo: Tapioca Powder for Cow's Milk Allergy. Completed, enrolled 41 participants across 1 site.

Detailed Summary

The purpose of this study is to determine whether baked milk oral immunotherapy is safe in the treatment of cow's milk allergy.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCow's Milk Allergy
CountriesUnited States
CollaboratorsMyra Reinhardt Foundation, La Jolla Institute for Allergy & Immunology

Timeline

Phase 2CompletedFinished
201820192020202120222023202420252026
First PostedMar 12, 2018
Enrollment StartMar 15, 2018
Primary CompletionJan 25, 2021
Study CompletionFeb 19, 2024
TodayJul 2, 2026
Enrollment to primary: 2.9 yearsPosted 8.3 years ago

Interventions

Baked non-fat cow's milk powderdrug

Oral immunotherapy with increasing quantities of baked milk.

Placebo: Tapioca Powderdrug

Placebo control.